166 Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8+ T Cells.
http://www.cell.com/cell-stem-cell/abstract/S1934-5909(12)00711-4
165 A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells.
http://www.cell.com/abstract/S0092-8674(12)01424-9
164 Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency.
http://www.nature.com/srep/2012/121212/srep00964/full/srep00964.html
163 Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways.
http://www.nature.com/nm/journal/v18/n12/abs/nm.2984.html
162 Identification of Oct4-activating compounds that enhance reprogramming efficiency.
http://www.pnas.org/content/109/51/20853.abstract
161 Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis.
http://stm.sciencemag.org/content/4/165/165ra164.abstract
160 Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy.
http://stm.sciencemag.org/content/4/165/165ra162.abstract
159 Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.
http://www.nature.com/nature/journal/v492/n7429/full/nature11629.html
158 In vivo directed differentiation of pluripotent stem cells for skeletal regeneration.
http://www.pnas.org/content/109/50/20379.abstract
157 Non-canonical TAF complexes regulate active promoters in human embryonic stem cells.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490149/
|
